U.S. stock indexes are drifting Thursday following a mixed set of earnings reports from Morgan Stanley, UnitedHealth Group ...

The prolonged slump reflects subdued investor sentiment, as many have reduced their buying activity amid ongoing market uncertainty ...

Sarepta Therapeutics' Elevidys for DMD shows revenue potential, with market cap justified at $11.4bn and potential for >50% ...

Goldman Sachs Group Inc.'s stock was up 1.3% to $614 a share on Thursday, a record stock price for the investment bank, a day after its stronger-than-expected fourth-quarter profit. If the gains hold ...

Discover high-yielding solutions to enhance your dividend investing portfolio and maximize returns. Click here to read what ...

Follow here to see if Wall Street can add to the big gains seen midweek after cooler inflation saw Treasury yields plunge, ...

Wall Street just went wild. Stocks posted their biggest gains since Trump took office again, with the S&P 500 climbing 1.8% ...

Live Updates Make sure to refresh this page periodically for updates. S&P 500 Winners 11:13 am What stocks are leading the ...

Demand for Big Data services is increasing. Palantir, a leader in the field, should benefit. Here are the forecasts and price ...

From 2022 to 2024, annuity sales topped $1.1 trillion, according to Limra, a global research organization for the insurance industry. In 2023 alone, annuity sales increased 23 percent over the prior ...

Indexes were slightly lower Thursday. Stocks dipped after posting the best day since November on Wednesday, fueled by bank ...

Wall Street pauses Thursday, with stocks little moved in early trade. Strong bank earnings keep rolling in and Senate ...